Reglagene is a groundbreaking brand that is transforming tubulin therapy for brain diseases. With a commitment to finding effective treatments, Reglagene aims to defy the complexities of developing therapies that effectively penetrate the brain. Their core expertise lies in designing and developing brain-penetrant medicines that can cross the blood-brain barrier, allowing them to confront brain diseases head-on.

The brand was founded in November 2016 by Dr. Richard Austin, Dr. Laurence Hurley, and Dr.

Vijay Gokhale, distinguished faculty members at the University of Arizona. Fueled by their passion for developing better solutions for patients with primary and secondary brain tumors, they established Reglagene. With a powerful drug development engine, Reglagene has cultivated a team of exceptional individuals who work tirelessly to bring new therapies to patients.

By pushing the boundaries of medical science and collaborating with renowned global service providers and esteemed academic partners, Reglagene is at the forefront of the industry. Their goal is to offer hope to patients battling brain cancers and other brain diseases, and they are currently working on developing breakthrough therapies for safe and effective treatments